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A B S T R A C T
The study was done to identify the predictors of refractory epilepsy in the North  Indian population
attending a tertiary care centre. This case–control study from August 2006 to December 2008 enrolled
200 consecutive patients of intractable epilepsy and 200 age matched controls with well controlled
epilepsy. The factors which were signiﬁcant in univariate analysis were age of onset before fourteen
years (OR 7.92), partial seizures (OR 6.27), presence of neurological deﬁcits (OR 19.68), perinatal insult
(OR 11.00), delayed milestones (OR 13.93), history of CNS infection (OR 7.45), febrile seizures (4.33),
high initial seizure frequency of more than one per month (OR 14.26), non response to ﬁrst Anti
Epileptic Drug (AED) (OR 6.71) and abnormal brain imaging (OR 20.47). On multivariate analysis
signiﬁcant predictors were radiological evidence of structural cerebral abnormality (OR 20.47), non
response to ﬁrst AED (OR 19.21), delayed mile stones (OR 9.09), high initial seizure frequency of more
than one per month (OR 6.71), partial seizure type (OR 6.27), febrile seizures (OR 5.66) and age of onset
before fourteen years (OR 3.09). It is thus possible to identify a certain proﬁle of patients with epilepsy
who are likely to be refractory to medical therapy. These observations would be useful in selecting
patients early for evaluation in Northern India where a high surgical treatment gap exists.
Crown Copyright  2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
It is estimated in various studies that the overall prevalence of
epilepsy in India is 5.59–10 per 1000.1–3 New onset epilepsy has a
good prognosis, only 10–20% of the patients develop medically
intractable epilepsy (MIE).4,5 Studies have shown that addition of a
second anti convulsant drug in patients with intractable epilepsy,
controls seizures in an additional 10–25% of cases with chances of
increased toxicity. Different risk factors have been associated with
intractable epilepsy. Berg et al.6 reported a history status epilepticus,
infantile spasms, neonatal seizures, microcephaly to be associated
with MIE. Kwan and Brodie7 found patients having many seizures
before treatment and inadequate response to initial treatment are
likely to have refractory epilepsy. Similarly Kwong et al.8 observed
abnormal neurologic status and early breakthrough attacks after
treatment initiation were predictors of MIE. Gururaj et al.9 in their
study population reported that developmental delay, neurological
deﬁcits, high frequency of seizures at onset and an abnormal brain
imaging were associated with intractability. An earlier study done in* Corresponding author. Tel.: +91 011 26594494/26588248 (O);
fax: +91 011 26588248/26588166, +91 9868398269/9868225507 (M).
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doi:10.1016/j.seizure.2011.07.010the pediatric population in India by Singhvi et al.10 found neuro
infections to be a leading cause of intractable epilepsy.
However, the magnitude of MIE in India is unknown. Whether
this can be predicted early on in the evolution of epilepsy is
unknown and there is limited data available speciﬁcally addressing
the risk factors and predictors associated with medically refracto-
riness. Besides, predictors of intractable epilepsy in an Indian
population may be different in view of different etiologies in India
compared to a developed country. Early identiﬁcation of patients
who are at high risk of developing intractable epilepsy would be
essential in parental counseling and selecting patients for more
intensive investigations and treatment for example early consid-
eration of surgery and to prevent toxicity from a overdose and
costs of AED, and useless poly therapy. It would be especially useful
in a resource poor setting where a small number of neurologists
deal with both pediatric and adult epilepsy patients and there
exists a large treatment gap both medical and surgical. We
therefore conducted this study in the realistic setting of this mixed
population aiming to ﬁnd early predictors of MIE.
2. Subject and methods
The present prospective case–control study was undertaken at
a tertiary referral centre in India from August 2006 to December
2008 in consecutive patients between ages of 2–60 years who. Published by Elsevier Ltd. All rights reserved.
Table 1
Characteristics of intractable and well controlled seizure.
Case (n = 200) Control (n = 200) P-Value
Age at onset of seizures 5.18  7.62 5.62  9.18 0.20
Gender
Male 142(71%) 128(64%) 0.13
Female 58(29%) 72(36%)
Initial seizure type
Partial onset 166(83) 113(56.5) <0.05
Generalized 14(7) 61(30.5)
Myoclonic 13(6.5) 25(12.5)
Mixed 7(3.5) 1(0.5)
Present seizure frequency
1–4/month 74(37%)
1–6/week 48(24%)
Daily 78(39%)
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adult patients since adult neurologists in our country also attend
many pediatric patients with epilepsy, especially those with MIE.
This age range was deﬁned to ﬁnd controls easily. A total of 200
consecutive persons of intractable and 200 of well controlled
epilepsy were included in this study.
Cases were deﬁned as having intractable epilepsy when they
had two or more seizures per month for a period of more than two
years with two or more antiepileptic drugs (AEDs)11 attending the
intractable epilepsy outpatient clinic. Cases were consecutively
recruited. We excluded patients whose seizures were poorly
controlled but in whom compliance was poor, those with sub
therapeutic serum drug concentration and those with non-
epileptiform events. Compliance was determined by questioning
the patients. Compliance was termed good if the patient
answered: ‘Yes, according to the given instructions’ to the
question: ‘Have you taken your drugs regularly?’ History of
irregular medication breaks or discontinuation of medication or
self manipulation of doses or intervals of dosing were interpreted
as poor compliance. Whenever in doubt, the information was
conﬁrmed by drug levels.
Controls consisted of consecutive age matched patients, who had
epilepsy and were attending the epilepsy outpatient clinic but had
no seizures of any type for a minimum of two years while receiving
the same dose of anti epileptic drugs. Patient with febrile seizures,
acute neurological infection, space occupying lesions (SOL) or
neurodegenerative diseases were excluded from the study.
Both cases and controls had a regular three monthly follow up
in the respective outpatient clinics.
The patients were recruited by UPP, MT and MVPS based on the
inclusion and exclusion criteria. There were monthly consensus
meeting amongst the assessors. Patients and their families were
interviewed and relevant records relating to the patient’s illness
were reviewed. The following data was obtained in a structured
questionnaire, age of onset of unprovoked seizure, initial seizure
type, number of seizures at baseline before start of treatment, and
onset seizure frequency (ﬁrst one year), present seizure frequency,
longest seizure free interval and details of AEDs and response to
ﬁrst AED, any history of status epilepticus (SE) before or as a part of
presentation, febrile convulsion, perinatal insult,12 delayed mile
stones, head trauma or any family history of seizure disorder.
Other clinical parameters included mental retardation (deﬁned as
IQ of less than 70) or behavioral abnormality, focal motor deﬁcits
and neuroimaging. Computed tomography was done in all
patients, epilepsy protocol magnetic resonance imaging was
performed in all patients with MIE. Previous relevant medical
records were reviewed and additional studies were carried out as
clinically indicated EEG, VEEG, Interictal and Ictal SPECT (SISCOS—
Ictal and Interictal SPECT subtraction). The syndromic diagnosis
was made according to the revised classiﬁcation by ILAE, 1989.13
Cases and controls were classiﬁed according to the risk factors and
clinical features in each group as well as epilepsy syndromes.
Ethical clearance was taken from Institutional Ethical Commit-
tee. The study was conducted after taking written informed
consent from all patients, explaining the nature and need of the
information.
2.1. Statistical analysis
We used chi square test for comparison of categorical data and
Mann–Whitney test for comparison of non parametric continuous
data. Odds ratios (OR) and 95% conﬁdence interval were calculated.
Potential interaction between factors was examined by logistic
regression method. Statistical calculations were performed with
use of SPSS software (version 16). A P value of <0.05 was
considered signiﬁcant.3. Results
This case–control study was conducted from August 2006 to
December 2008. 200 patients of intractable epilepsy (case) and 200
patients of well controlled epilepsy conforming to eligibility
criteria were included in this study.
A comparison of intractable and well controlled groups
showed several differences (Table 1). Age of onset varied from
1 year to 55 years and majority of patients in the intractable group
had onset of seizures before the age of 14 years. Most of the cases
and controls were males (71% and 64% respectively). This is due to
the socio cultural referral bias of families of giving better medical
attention to male subjects. In intractable group 83% of patients
had partial seizures, 7% had a generalized onset, 6.5% had
myoclonic seizure at onset and 3.5% had presented with multiple
seizure types, where as in the well controlled group 56.5% patients
presented with partial seizures, generalized seizure was the
clinical presentation in 30.5% patients, and 12.5% patients had
myoclonic seizures as the initial presentation. Status epilepticus
was seen in 7% of patients in the intractable epilepsy group and
2.5% in patients with good control. History of delayed mile stones
was found in 18% of patients of intractable epilepsy and only 1% in
well controlled group, similarly history of perinatal insult was
found in 23% of patients. 10% of patients of intractable group had
history of febrile seizure where as only 2.5% patients of control had
febrile seizures. More than 90% patients in the well controlled
group had favorable response to ﬁrst AED where as only 10% of the
intractable group had reported initial favorable response to ﬁrst
AED. Abnormal brain imaging was seen in 79% of the patients in
intractable group and only 39% of the patients in well control
group. Post infectious causes, predominantly neurocysticercosis
(NCC) were associated in 13% of the intractable group. 83% of the
patients of intractable group had history of high seizure frequency
(more than one per month) in their initial two years of onset of
seizures where as only 25% of patients in the well control group
had a frequency of more than one per month. However family
history of seizures, history of head trauma and behavioral
disorders were not found to be signiﬁcantly different between
the two groups. The present study is tertiary care hospital-based
wherein independent predictors of intractability showed strong
univariate association between the age of onset before the age of
14 yrs, high initial seizure frequency, partial seizure types,
presence of neurological deﬁcits, perinatal insult, history of status
epilepticus, febrile convulsions, history of delayed mile stones,
febrile encephalopathy, non response to ﬁrst AEDs and presence of
known radiological epileptogenic structural lesions (Table 2).
These variables were factored for multivariate analysis.
The cases and controls were categorized according to the ILAE,
1989 classiﬁcation,13 and further subdivided into age groups of
<14 years and 14 years. The maximum numbers of patients were
Table 2
Univariate comparison of intractable and well controlled group.
Prognostic factors Cases (n = 200) Controls (n = 200) OR 95% CI P-Value
Age of onset of seizures
<14 years 144(72%) 151(75%) 1 0.49
14 years 56(28%) 49(24.5%)
Gender
Male 142(71%) 128(64%) 1.38 0.90–2.10 0.13
Female 58(29%) 72(36%)
Type of initial seizure
Partial 166(83%) 113(56%) 6.27 2.01–19.60 <0.05
Generalized 14(7%) 61(30.5%)
Myoclonic 13(6.5%) 25(12.5%)
Other mixed 7(3.5%) 1(0.5%)
Clinical features
History of status epilepticus 14(7.0%) 5(2.5%) 2.93 1.04–8.31 0.03*
Neurological deﬁcits 18(9.0%) 1(0.5%) 19.68 2.60–148.91 <0.05
History of perinatal insult 44(22.0%) 5(2.5%) 11.00 4.26–28.40 <0.05
History of delayed mile stones 35(17.5%) 3(1.5%) 13.93 4.20–46.11 <0.05
History of CNS infection 14(7%) 2(1%) 7.45 1.67–33.23 <0.05
Febrile seizure 20(10%) 5(2.5%) 4.33 1.59–11.79 <0.05
Behavioral disorder 3(1.5%) 2(1.0%) 1.51 0.25–9.12 0.65
History of signiﬁcant head trauma 11(5.5%) 7(3.5%) 1.60 0.61–4.23 0.33
Initial 2 yr seizure frequency
<1/month 34(17%) 149(74.5%) 14.26 8.76–23.21 <0.05
>1/month–few/week 166(83%) 51(25.5%)
Family history of seizure 10(5%) 14(7%) 0.699 0.30–1.61 0.40
Non response to ﬁrst AED 190(95%) 10(5%) 6.71 3.16–14.28 <0.05
Abnormal brain imaging
Known epileptogenic structural lesions,
post infectious (NCC, post TBM. etc.)
133(66.5%) 15(7.5%) 20.46 8.18–51.20 <0.05
Normal 26(13%) 63(31.5%)
Non speciﬁc (cortical atrophy, periventricular
white matter changes, calciﬁc specks, etc.)
41(20.5%) 122(61%)
NCC—neurocysticercosis, TBM—tuberculous meningitis.
Table 3
Distribution of cases and controls according to the epilepsy syndromes.
Epilepsy syndrome Cases (n = 200) Controls (n = 200)
<14 years 14 years <14 years 14 years
Localization related 32 79 11 115 237(59.2%)
Idiopathic 0 0 5 32
Symptomatic 31 72 6 83
Cryptogenic 1 7 0 0
Generalized 44 37 10 54 145(36.3%)
Idiopathic 2 3 5 3
Cryptogenic or symptomatic 38 32 0 0
Symptomatic 4 2 5 1
Undetermined 4 0 0 0 4(1.0%)
Special syndromes 2 2 6 4 14(3.5%)
Table 4
Multivariate comparison of intractable and well controlled group.
Prognostic factors OR 95% CI P-Value
Abnormal brain imaging 20.47 8.18–51.19 <0.005
Initial seizure frequency 6.71 3.16–14.28 <0.005
Partial seizure type 6.27 2.01–19.60 0.002
Febrile seizure 5.66 1.36–23.49 0.017
Non response to ﬁrst AED 19.21 7.41–49.80 <0.005
History of delayed mile stones 9.09 1.35–61.05 0.023
Age of onset < 14 years 3.09 1.46–6.53 <0.005
AED—anti epileptic drug.
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(63%) amongst controls. However the number of symptomatic
localization related epilepsy (31/103 (30.1%)) was signiﬁcantly
more in the pediatric intractable group as compared to the well
controlled group (6/89 (6.7%)) (P < 0.001) (Table 3). Amongst
generalized epilepsy syndromes, the cryptogenic or symptomatic
patients were present only in the MIE group, both in pediatric and
adult population (Table 3).
On multivariate analysis signiﬁcant predictors of intractability
were radiological evidence of structural cerebral abnormality (OR
20.47), Non response to ﬁrst AED (OR 19.21), delayed mile stones
(OR 9.09), high initial seizure frequency of more than one per
month (OR 6.71), partial seizure type (OR 6.27), age of onset before
fourteen years (OR 3.09) and febrile convulsion (OR 5.66) (Table 4).
We further did multivariate analysis for the predictors based
on the age group of the patients, to see whether they were any
different in pediatric and adult population (Tables 5 and 6).
In patients less than 14 years of age, all factors except presence
of febrile seizures were signiﬁcant. In patients 14 years of
age, delayed milestones further dropped its signiﬁcance onmultivariate analysis. Thus the predictors were not very
different in the pediatric and adult population.
4. Discussion
Determining the prognosis of patients when they ﬁrst present
with epilepsy is a difﬁcult task. MIE patients are more prone to
drug toxicity resulting from poly pharmacy and are risk of
Table 5
Multivariate comparison of intractable and well controlled group (<14 yrs).
Prognostic factors OR 95% CI P-Value
Abnormal brain imaging. Known
epileptogenic structural lesions
19.16 7.532–52.12 <0.005
Non response to 1st AED 17.29 2.78–113.27 <0.002
History of delayed mile stones 17.77 2.78–113.27 <0.002
Partial seizure type 11.39 3.34–38.573 <0.005
Initial seizure frequency (1st yr) 8.37 3.78–18.49 <0.001
Table 6
Multivariate comparison of intractable and well controlled group (14 yrs).
Prognostic factors OR 95% CI P-Value
Abnormal brain imaging. Known
epileptogenic structural lesions
20.97 7.84–51.57 <0.001
Initial seizure frequency (1st yr) 20.95 5.95–73.810 <0.001
Non response to 1st AED 13.865 3.10–62.012 <0.001
Partial seizure type 15.66 2.516–97.572 <0.003
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tion of patients who are at high risk of developing intractable
epilepsy is important because patients or their parents can be
properly counseled. Surgically treatable cases could be selected
early in their clinical course for intensive investigations.
Our study shows that presence of a known epileptogenic
structural lesion is the most important predictor of intractable
epilepsy. The most common radiological features in the intractable
group were known epileptogenic structural abnormalities such as
(Mesial Temporal Sclerosis (MTS), Dysembryoplastic Neuroepithe-
lial Tumor (DNET), and perinatal hypoxic ischemic brain injuries).
Post infectious causes, predominantly NCC were seen in 13% of the
intractable group. Earlier studies conducted in a tertiary centre in
India by Singhvi et al.10 also had similar observation. Single CT
enhancing lesions and neurocysticercosis together accounted for
67% of the provoking factors of acute symptomatic seizures in
another study conducted in India.14 The study illustrated that the
etiological spectrum of acute symptomatic seizures in this part of
the world is different from that described from developed
countries and central nervous system (CNS) infections account
for a signiﬁcant number of cases. However it did not answer how
many of such patients had MIE. Ohtsuka et al.15 reported CNS
infection as the most characteristic ﬁnding of underlying cause in
localization related epilepsy. Some studies7,9,10 have reported
remote symptomatic epilepsy was most important cause associ-
ated with intractability. A number of other studies have also
reported association of structural cerebral abnormality with
intractability as observed in our study.16,17
Non response to the ﬁrst antiepileptic drug is the second most
important prognostic factor in our study. A number of studies
demonstrated that early response to therapy confers a favorable
prognosis.18,19 Patients who have many seizures before therapy or
who have an inadequate response to initial treatment with
antiepileptic drugs are likely to have refractory epilepsy. Failure
of the ﬁrst AED trial accurately predicts refractory temporal lobe
epilepsy (TLE) at two years after onset, based on retrospective
cohort data in children.20
Initial seizure frequency was identiﬁed to be a signiﬁcant
prognostic factor in our study as well. Almost one quarter of our
intractable seizure group had daily seizures and most of them had
more than one seizure per month and very few had less than one
seizure per month. Sillanpa¨a¨19 in a follow up study for 30 years had
similar observations. Shinnar et al.21 reported that in children with
two seizures, an interval of less than 6 months between the
seizures was predictive of having multiple seizures In a recent
study, a model comprising three variables (etiology, age at onset of
epilepsy and number of seizures during the ﬁrst 6 months afterdiagnosis) has tried to classify patients in groups with low,
intermediate and high risk of refractory epilepsy.22
We observed that febrile seizures were an independent factor
for intractable seizures. The association between febrile seizures
and seizure intractability is controversial. Kwong et al.8 found it as
signiﬁcant on multivariate but not in univariate analysis. There are
studies that did not ﬁnd febrile seizures to be associated with
seizure outcome.23 Berg et al.24 even observed a slightly protective
association between febrile seizures and intractability. However
Camﬁeld et al.25 observed that prolonged febrile seizures were
associated with intractable epilepsy. Our study shows that febrile
seizures do contribute to intractability, although the character-
istics like prolonged or atypical febrile seizures were not studied.
This factor also looses signiﬁcance when patients are categorized
according to age groups.
The correlation between the presence of developmental delay
and poor outcome may represent widespread, albeit subtle,
cortical structural abnormalities. Such a theory may also underlie
the more intractable cases of cryptogenic epilepsies and the large
proportion of patients with associated co-morbid conditions.
In accordance with other authors7,10,26 we observed that early
age at onset was an inﬂuential predictor on univariate analysis and
it was retained in multivariate analysis. Early age of onset was
observed frequently in the remote symptomatic group and those
who were neurologically abnormal. Berg et al.6 also reported that
the predictive value of age appeared throughout the whole age
range in their study population.
Partial seizure type was found to be independent predictor of
intractability in our study. Mattson et al.27 observed poor seizure
control in patients with partial seizures as compared to general-
ized seizure after one year of treatment. However there are studies
which found that generalized and myoclonic seizures have the
worst outcome6,28,29 and also some who did not ﬁnd seizure type
as a predictor of intractability.30,31 This study did not identify
catastrophic epilepsy syndromes as the patients were classiﬁed
according to seizure type.
When the patients were categorized according to epilepsy
syndromes and further into pediatric and adult groups, the
signiﬁcant ﬁndings were that a high number MIE patients of
pediatric age group suffered from symptomatic localization related
epilepsy and the cryptogenic or symptomatic generalized epilepsy
was found in both pediatric and adult patients with MIE. This
further points out toward the large treatment gap in our
population.
The present study was conducted in a tertiary care hospital,
where cases of intractable epilepsy are often referred for
evaluation as this is the major centre performing epilepsy
surgeries in Northern India.32 The limitation is that the study
population may not be truly representative of the population
considered however most difﬁcult to control epilepsies in
Northern India eventually get referred to our centre due to
disparity of resources. One concern in case–control studies is that
ascertaining a history of various risk factors will be different in
cases and controls because of recall or related biases. Although we
recorded information prospectively but the information recorded
could suffer from recall bias.
Our study suggests that the risk of developing intractable
epilepsy may be predicted, to some extent, at an early course of
illness when structural neuroradiological abnormality in the brain,
non response to initial antiepileptic drugs, partial seizures types,
high initial seizure frequency, early onset of seizures and a history
of developmental delay seem to be consistent predictors of
intractability.
Our ﬁndings offer support for the hypothesis that some patients
may have refractory epilepsy from the beginning rather than
evolve over time, since the clinical characteristics of intractable
M. Tripathi et al. / Seizure 20 (2011) 779–783 783epilepsy are apparent early in the course of disease and such
patients are more likely to have underlying structural cerebral
abnormalities.
Our observations would be useful in selecting patients for
intensive investigations early in their clinical course for a possible
surgical treatable cause; proper parental counseling and preven-
tion of toxicity from an overdose of antiepileptic drugs and useless
polytherapy can be minimized, in a country like India where a large
treatment gap exists.
Conﬂict of interest statement
The authors report no conﬂict of interest. The study is not
supported by any grant.
References
1. Sridharan R, Murthy BN. Prevalence and pattern of epilepsy in India. Epilepsia
1999;40(5):631–6.
2. Sridharan R. Epidemiology of epilepsy. Curr Sci 2002;82(6):664–70.
3. Goel D, Agarwal A, Dhanai JS, Semval VD, Mehrotra V, Saxena V, et al. Compre-
hensive rural epilepsy surveillance programme in Uttarakhand state of India.
Neurol India 2009;57:355–6.
4. Harrison RM, Taylor DC. Childhood seizures: a 25-year follow up. Social and
medical prognosis. Lancet 1976;1(7966):948–51.
5. Sillanpa¨a¨ M. Remission of seizures and predictors of intractability in long-term
follow-up. Epilepsia 1993;34(5):930–6.
6. Berg AT, Levy SR, Novotny EJ, Shinnar S. Predictors of intractable epilepsy in
childhood: a case–control study. Epilepsia 1996;37(1):24–30.
7. Kwan P, Brodie MJ. Early identiﬁcation of refractory epilepsy. N Engl J Med
2000;342(5):314–9.
8. Kwong KL, Sung WY, Wong SN, So KT. Early predictors of medical intractability
in childhood epilepsy. Pediatr Neurol 2003;29(1):46–52.
9. Gururaj A, Sztriha L, Hertecant J, Eapen V. Clinical predictors of intractable
childhood epilepsy. J Psychosom Res 2006;61(3):343–7.
10. Singhvi JP, Sawhney IM, Lal V, Pathak A, Prabhakar S. Proﬁle of intractable
epilepsy in a tertiary referral center. Neurol India 2000;48(4):351–6.
11. Berg AT, Kelly MM. Deﬁning intractability: comparisons among published
deﬁnitions. Epilepsia 2006;47(2):431–6.
12. Cowan F, Rutherford M, Groenendaal F, Eken P, Mercuri E, Bydder GM, et al.
Origin and timing of brain lesions in term infants with neonatal encephalopa-
thy. Lancet 2003;361(9359):736–42.
13. Proposal for revised classiﬁcation of epilepsies and epileptic syndromes. Com-
mission on Classiﬁcation and Terminology of the International League Against
Epilepsy. Epilepsia 1989;30(4):389–99.14. Murthy JM, Yangala R. Acute symptomatic seizures—incidence and etiolog-
ical spectrum: a hospital-based study from south India. Seizure 1999;8:
162–5.
15. Ohtsuka Y, Yoshinaga H, Kobayashi K, Murakami N, Yamatogi Y, Oka E, et al.
Predictors and underlying causes of medically intractable localization-related
epilepsy in childhood. Pediatr Neurol 2001;24(3):209–13.
16. Shafer SQ, Hauser WA, Annegers JF, Klass DW. EEG and other early predictors of
epilepsy remission: a community study. Epilepsia 1988;29(5):590–600.
17. Semah F, Ryvlin P. Can we predict refractory epilepsy at the time of diagnosis?
Epileptic Disord 2005;7(S1):S10–3.
18. Annegers JF, Hauser WA, Elveback LR. Remission of seizures and relapse in
patients with epilepsy. Epilepsia 1979;20(6):729–37.
19. Sillanpa¨a¨ M. Children with epilepsy as adults: outcome after 30 years of follow-
up. Acta Paediatr Scand Suppl 1990;368:1–78.
20. Dlugos DJ, Sammel MD, Strom BL, Farrar JT. Response to ﬁrst drug trial predicts
outcome in childhood temporal lobe epilepsy. Neurology 2001;57:2259–64.
21. Shinnar S, Berg AT, O’Dell C, Newstein D, Moshe SL, Hauser WA. Predictors of
multiple seizures in a cohort of children prospectively followed from the time
of their ﬁrst unprovoked seizure. Ann Neurol 2000;48(2):140–7.
22. Ramos-Lizana J, Aguilera-Lo´pez P, Aguirre-Rodrı´guez J, Cassinello-Garcı´a E.
Early prediction of refractory epilepsy in childhood. Seizure 2009;18(6):412–6.
23. Arts WF, Geerts AT, Brouwer OF, Boudewyn Peters AC, Stroink H, van
Donselaar CA. The early prognosis of epilepsy in childhood: the prediction
of a poor outcome. The Dutch study of epilepsy in childhood. Epilepsia
1999;40(6):726–34.
24. Berg AT, Shinnar S, Levy SR, Testa FM, Smith-Rapaport S, Beckerman B. Early
development of intractable epilepsy in children: a prospective study. Neurology
2001;56(11):1445–52.
25. Camﬁeld P, Camﬁeld C, Gordon K, Dooley J. What types of epilepsy are preceded
by febrile seizures? A population-based study of children. Dev Med Child Neurol
1994;36(10):887–92.
26. Elwes RD, Johnson AL, Shorvon SD, Reynolds EH. The prognosis for seizure
control in newly diagnosed epilepsy. N Engl J Med 1984;311(15):944–7.
27. Mattson RH, Cramer JA, Collins JF. Prognosis for total control of complex partial
and secondarily generalized tonic clonic seizures. Department of Veterans
Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group. Neurology
1996;47(1):68–76.
28. Chawla S, Aneja S, Kashyap R, Mallika V. Etiology and clinical predictors of
intractable epilepsy. Pediatr Neurol 2002;27(3):186–91.
29. Eriksson KJ, Koivikko MJ. Prevalence, classiﬁcation, and severity of epilepsy and
epileptic syndromes in children. Epilepsia 1997;38(12):1275–82.
30. Camﬁeld C, Camﬁeld P, Gordon K, Smith B, Dooley J. Outcome of childhood
epilepsy: a population-based study with a simple predictive scoring system for
those treated with medication. J Pediatr 1993;122(6):861–8.
31. Huttenlocher PR, Hapke RJ. A follow-up study of intractable seizures in child-
hood. Ann Neurol 1990;28(5):699–705.
32. Sanyal SK, Chandra PS, Gupta S, Tripathi M, Singh VP, Jain S, et al. Memory and
intelligence outcome following surgery for intractable temporal lobe epilepsy:
relationship to seizure outcome and evaluation using a customized neuropsy-
chological battery. Epilepsy Behav 2005;6(2):147–55.
